Landscapes / Companies

BioCryst Pharmaceuticals not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
BCX17725, Phase 1 trial completes
Drugs
2
in active trials · 7 in all
Trials
3 active
24 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Plasma kallikrein inhibitor
Approved Aug 2031Phase 3 trial completes
—
Phase 1 Dec 2026Phase 1 trial completes

About

No active trial
avoralstat, BCX10013, BCX9930, Galidesivir, Peramivir
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow BioCryst Pharmaceuticals

Following is part of Solo: you see every change to BioCryst Pharmaceuticals the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in